M.M. Matuszak
- Radiation top 0.2%
- Advanced Radiotherapy Techniques 93
-
- Radiomics and Machine Learning in Medical Imaging 28
- Effects of Radiation Exposure 27
- Medical Imaging Techniques and Applications 22
- Advances in Oncology and Radiotherapy 18
- Health Informatics top 2%
-
- Lung Cancer Diagnosis and Treatment 51
- Radiation Therapy and Dosimetry 22
- Lung Cancer Treatments and Mutations 16
- Hepatology top 5%
- Co-authors
- Randall K. Ten HakenTheodore S. LawrenceFeng‐Ming KongMatthew J. SchipperShruti JollyJames A. HaymanJean M. MoranInga S. Grills
- Partner nations
- United StatesChinaCanada
In The Last Decade
M.M. Matuszak
157 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Radiation 1.6k
- Radiology, Nuclear Medicine and Imaging 1.6k
- Health Informatics 73
- Pulmonary and Respiratory Medicine 1.6k
- Hepatology 226
Countries citing papers authored by M.M. Matuszak
This map shows the geographic impact of M.M. Matuszak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.M. Matuszak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.M. Matuszak more than expected).
Fields of papers citing papers by M.M. Matuszak
This network shows the impact of papers produced by M.M. Matuszak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.M. Matuszak. The network helps show where M.M. Matuszak may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M.M. Matuszak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 5 | |
| 3 | 2023 | 27 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 3 | |
| 6 | NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastomabreakdown → | 2022 | 104 |
| 7 | 2022 | 0 | |
| 8 | 2021 | 6 | |
| 9 | 2021 | 7 | |
| 10 | 2020 | 9 | |
| 11 | 2020 | 40 | |
| 12 | 2019 | 13 | |
| 13 | 2018 | 1 | |
| 14 | 2017 | 2 | |
| 15 | Effect of Midtreatment PET/CT-Adapted Radiation Therapy With Concurrent Chemotherapy in Patients With Locally Advanced Non–Small-Cell Lung Cancer | 2017 | 9 |
| 16 | 2016 | 61 | |
| 17 | 2015 | 1 | |
| 18 | 2015 | 28 | |
| 19 | 2013 | 21 | |
| 20 | Controlling Beam Complexity in Intensity Modulated Radiation Therapy. | 2007 | 2 |
About M.M. Matuszak
M.M. Matuszak is a scholar working on Radiation, Radiology, Nuclear Medicine and Imaging and Otorhinolaryngology, having authored 169 papers that have together received 3.1k indexed citations. Recurring topics across this work include Advanced Radiotherapy Techniques (93 papers), Lung Cancer Diagnosis and Treatment (51 papers), Radiomics and Machine Learning in Medical Imaging (28 papers), Effects of Radiation Exposure (27 papers), Medical Imaging Techniques and Applications (22 papers), Radiation Therapy and Dosimetry (22 papers), Advances in Oncology and Radiotherapy (18 papers) and Lung Cancer Treatments and Mutations (16 papers). The work is most often cited by research in Radiation (1.6k citations), Radiology, Nuclear Medicine and Imaging (1.6k citations) and Health Informatics (73 citations). M.M. Matuszak has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Randall K. Ten Haken, Theodore S. Lawrence, Feng‐Ming Kong, Matthew J. Schipper, Shruti Jolly, James A. Hayman, Jean M. Moran, Inga S. Grills, Issam El Naqa and Daniel L. McShan. Their work appears in journals such as Journal of Clinical Oncology, Nature Biotechnology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.